Uricosuric Drugs, with Special Reference to Probenecid and Sulfinpyrazone (Q40041425)

16 September 2017

1 reference

title

Uricosuric drugs, with special reference to probenecid and sulfinpyrazone (English)

1 reference

16 September 2017

Uricosuric Drugs, with Special Reference to Probenecid and Sulfinpyrazone (English)

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60098-8

3 May 2023

author name string

A. B. Gutman

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5333771

3 May 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=5333771

3 May 2023

publication date

1 January 1966

1 reference

16 September 2017

published in

Advances in pharmacology

1 reference

16 September 2017

volume

4

1 reference

16 September 2017

page(s)

91-142

1 reference

Effect of pH and Chloride Ions on Plasma Kininase Activity

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

EXCRETION OF URINARY KININ IN MAN

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

BRADYKININ AND FOREARM BLOOD FLOW

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Kinin-forming and destroying activities of cell homogenates

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Kininase Inhibition by a Fluorescent Substance Prepared from Liver

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

The isolation and amino acid sequence of eledoisin, the active endecapeptide of the posterior salivary glands of Eledone

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

OCCURENCE OF BRADYKININ IN THE SKIN OF RANA TEMPORARIA.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Purification of bradykinin by ion-exchange chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Coronary vasodilation produced by bradykinin on isolated mammalian heart

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Possible significance of bradykinin in the Shwartzman and other phenomena

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Spontaneous Plasma Kinin Formation in Human Plasma collected during Labour

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Anti-Heparin Agents as Inhibitors of Plasma Kinin Formation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Observations on chemical excitants of cutaneous pain in man

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Development of Pain-producing Substance in Human Plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Pain-producing substance in human inflammatory exudates and plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Quantitative relation between certain fibrinolysis factors and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

ACTIVATION OF BOVINE BRADYKININOGEN BY HUMAN PLASMIN

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

On the relationship between plasmin and kinin

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Anaphylactic shock in dogs. Role of fibrinolysin and vasoactive polypeptide systems

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

THE ACTION OF VASOPRESSIN, A VASOPRESSIN ANALOGUE (PLV2), OXYTOCIN, ANGIOTENSIN, BRADYKININ AND THEOPHYLLINE ETHYLENE DIAMINE ON RENAL BLOOD FLOW IN THE ANAESTHETIZED CAT

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

THE PERMEABILITY GLOBULINS OF HUMAN SERUM AND THE BIOCHEMICAL MECHANISM OF HEREDITARY ANGIONEUROTIC EDEMA

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Enzymic Nature of the Serum Globulin Permeability Factor

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Formation of bradykinin in anaphylactic and peptone shock

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Substance U; a depressor and smooth-muscle stimulating principle present in urine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Experiments on the factor in urine forming substance U

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Effect of Bradykinin on Uterine Activity

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

EFFECT OF THE ENDECAPEPTIDE ELEDOISIN ON THE CORONARY BLOOD FLOW: COMPARISON WITH NITROGLYCERIN, BRADYKININ AND EPINEPHRINE IN THE DOG

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

PERIPHERAL VASODILATOR ACTION OF ELEDOISIN, BRADYKININ, AND NITROGLYCERIN IN ANESTHETIZED DOGS

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Permeability response of cerebral and cutaneous blood vessels to vasoactive agents.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Synthetic peptides related to eledoisin

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

The effect of bradykinin, serum kallikrein and other endogenous substances on capillary permeability inthe guinea-pig

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Identification of acetylcholine, 5-hydroxy-tryptamine, histamine, and a new kinin in hornet venom (V. crabro).

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Release of kinin by an enzyme in the accessory sex glands of the guinea-pig

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Vasodilatation in the submaxillary gland of the cat.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Relationships between the chemical structures and the biological properties of the posterior pituitary hormones and their synthetic analogues

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

[STUDIES ON THE CIRCULATORY EFFECT OF ELEDOISIN IN HUMANS AND EXPERIMENTAL ANIMALS]

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Central effects of peptides on the cardiovascular system

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Bradykinin, digital blood flow, and the arteriovenous anastomoses

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

SYNTHETIC PEPTIDES RELATED TO ELEDOISIN. I

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Cerebral vascular action of bradykinin in the dog.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

THE EVALUATION OF INCREASED VASCULAR PERMEABILITY IN THE SKIN OF GUINEA-PIGS

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

The kinin content of human blood at rest and during vasodilatation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

KININ-FORMING ENZYME (KININOGENIN) IN RAT KIDNEY

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

THE PARTICIPATION OF THE NERVOUS SYSTEM IN THE INFLAMMATORY REACTION

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Augmentation of the inflammatory reaction by activity of the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Neurohumoral features of afferent fibers in man. Their role in vasodilation, inflammation, and pain

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

A COMPARATIVE STUDY OF THE EFFECTS OF BRADYKININ, KALLIDIN II AND ELEDOISIN ON SEGMENTAL SUPERIOR MESENTERIC RESISTANCE

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Effect of trypsin inhibitors on Shwartzman phenomenon

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

EFFECT OF INHIBITORS OF FIBRINOLYTIC ENZYMES ON DEVELOPMENT OF PULMONARY METASTASES

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

CALF BLOOD FLOW AND OXYGEN USAGE DURING BRADYKININ INFUSIONS

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

The action and antagonism of kinins on bronchioles

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

BRONCHOCONSTRICTOR ACTION OF BRADYKININ, KALLIDIN AND ELEDOISIN.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Rapid Induction by Acetylcholine, Bradykinin and Potassium of a Nociceptive Response in Mice and its Selective Antagonism by Aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Antagonistic Action of Urokinase to Brady-kinin- and Plasminogen-induced Capillary Permeability

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Proteolytic activity in development of pain and itching. Cutaneous reactions to bradykinin and kallikrein

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

STUDIES ON THE EFFECTS OF A TRYPSIN INHIBITOR (TRASYLOL) ON ENZYME ACTIVITIES AND MORPHOLOGY IN TAUROCHOLATE AND CALCIPHYLAXIS PANCREATITIS OF THE RAT (A CONTRIBUTION TO THE PATHOGENESIS OF PANCREATITIS. II.)

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Hypertensive Effects of Bradykinin in Rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

THE IMPORTANCE OF BRADYKININ IN ANAPHYLACTIC SHOCK

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

GENERAL CIRCULATORY ALTERATIONS INDUCED BY INTRAVENOUS INFUSIONS OF SYNTHETIC BRADYKININ IN MAN

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

THE SYNTHESIS OF 6-O-CARBAMYL-L-SERINE, 6-D-SERINE, AND 6-L-THREONINE BRADYKININ.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

A micromethod for determination of bradykininogen under several conditions

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

ACTION OF COMPLEMENT IN HEREDITARY ANGIONEUROTIC EDEMA: THE ROLE OF C'1-ESTERASE

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

KININ-FORMING ACTIVITY AND HISTAMINE IN LYMPH AFTER TISSUE INJURY

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Kinin formation and fibrinolysis in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Methionyl-lysyl-bradykinin, a new kinin from ox blood

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Proceedings of the Biochemical Society

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Actions of pure bradykinin

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

The isolation of bradykinin, a plasma kinin from ox blood

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

BRADYKININ WRITHING: A METHOD FOR MEASURING ANALGESIA

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

An enzyme in human blood plasma that inactivates bradykinin and kallidins

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

INHIBITION IN VIVO OF THE ENZYMATIC INACTIVATION OF BRADYKININ AND KALLIDIN

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

CARBOXYPEPTIDASE IN BLOOD AND OTHER FLUIDS. I. PROPERTIES, DISTRIBUTION, AND PARTIAL PURIFICATION OF THE ENZYME.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

CARBOXYPEPTIDASE IN BLOOD AND OTHER FLUIDS. VALUES IN HUMAN BLOOD IN NORMAL AND PATHOLOGICAL CONDITIONS

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

1 reference

7 January 2021

Structure and pharmacological actions of eledoisin, the active endecapeptide of the posterior salivary glands of Eledone

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Structure and pharmacological actions of physalaemin, the main active polypeptide of the skin ofPhysalaemus fuscumaculatus

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

SPECIFICITY OF MAMMALIAN KALLIDINOGEN.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

The role of mediators in the inflammatory tissue response

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Some observations on salivary secretion

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

THE ACTION OF PEPTIDES ON THE ADRENAL MEDULLA. RELEASE OF ADRENALINE BY BRADYKININ AND ANGIOTENSIN

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Potentiation of bradykinin by dimercaptopropanol (bal) and other inhibitors of its destroying enzyme in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Bradykinin formation in human skin as a factor in heat vasodilatation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Bradykinin as a vasodilator in man

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

ACTIVITY OF ELEDOISIN, OTHER POLYPEPTIDES AND ERGOMETRINE ON THE UTERUS IN SITU OF RABBIT AND OTHER ANIMAL SPECIES

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Vascular Permeability Factors in the Secretion of the Guinea Pig Coagulating Gland

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

TRITIUM-LABELLING AND ORGAN DISTRIBUTION OF A BASIC POLYPEPTIDE WITH LEUKOTACTIC AND PERMEATION-ACCELERATING EFFECT

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

HEMODYNAMIC EFFECTS OF ELEDOISIN IN MAN

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

[On circulatory effects of synthetic bradykinin in man and waking dogs]

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

CIRCULATORY RESEARCH ON ELEDOISIN WITH RESULTS OF THERAPY

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

BRONCHOCONSTRICTOR ACTION OF BRADYKININ, KALLIDIN AND ELEDOISIN

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

APNEA AFTER BRADYKININ AND KALLIDIN

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

[ON THE STIMULATION OF RESPIRATION BY BRADYKININ AND KALLIDIN]

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Nature of peptides released by thrombin

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

PATHOGENESIS OF INFLAMMATION. II. IN VIVO OBSERVATIONS OF THE INFLAMMATORY EFFECTS OF ACTIVATED HAGEMAN FACTOR AND BRADYKININ

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Studies on the isolation of bradykininogen

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

CATHEPTIC DEGRADATION OF BRADYKININ

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

STUDIES OF THE PEPTIC DEGRADATION OF BOVINE BRADYKININOGEN.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

The secretagogue and depressor substances in saliva and pancreatic juice

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

The effect of bradykinin on vascular smooth muscle

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

[Separation and purification of pancreatic kallikrein]

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

[Differentiation between kallikrein and kallikrein elements by means of antiserum and diisopropylfluorophosphate]

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Snake venoms, kallikreins, and kininogen

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

[Identification of a "spontaneous" peptide formed from serum globulin with bradykinin]

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

[PARTIAL PURIFICATION AND PROPERTIES OF A KININOGEN FROM BOVINE BLOOD]

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

INHIBITION OF THE LOCAL HEMORRHAGIC SHWARTZMAN REACTION BY A POLYPEPTIDE POSSESSING POTENT ANTIPROTEASE ACTIVITY

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Isolation and molar activity of human bradykinin

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

A large scale preparation of bradykinin

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Studies on the enzymatic inactivation of bradykinin

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Isolation and amino acid composition of bradykinin released by venom of Bothrops jararaca from bovine plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

[THE EFFECTS OF BRADYKININ AND KALLIDIN ON KIDNEY FUNCTION IN DOGS]

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Bradykinin-releasing Factor from Bothrops jararaca venom

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Partial purification of the plasma substrate for the bradykinin-releasing enzyme from the venom of Bothrops jararaca

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Weal and Flare in Human Skin Produced by Histamine and other Substances

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

The relationship between glandular activity, bradykinin formation and functional vasodilatation in the submandibular salivary gland

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Use of crystalline soybean trypsin inhibitor in acute hemorrhagic pancreatitis in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

ENHANCEMENT OF FIBRINOLYSIS IN THE DOG BY INJECTION OF VASOACTIVE DRUGS

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

THE ENZYMIC INACTIVATION OF SOME PHYSIOLOGICALLY ACTIVE POLYPEPTIDES BY DIFFERENT PARTS OF THE NERVOUS SYSTEM.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

The estimation of urinary kallikrein

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

The role of bradykinin in the peripheral nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

A comparison of the plasma kinin forming enzymes in urine; kallikrein and urokinase

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Depressor polypeptides

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

THE ENZYMATIC FORMATION OF THE VASORPRESSOR POLYPEPTIDE SUBSTANCE A BY A CRYSTALLINE ENZYME OF BACILLUS SUBTILUS.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Bradykinin antagonism following oral protease therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Pharmacological characteristics of bradykinin B

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

EXCRETION OF HUMAN URINARY KININS

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

THE PRESENCE OF TWO PERMEABILITY GLOBULINS IN HUMAN SERUM

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

TRYPSIN RELEASE, KININ PRODUCTION, AND SHOCK; RELATIONSHIP IN EXPERIMENTAL AND HUMAN PANCREATITIS

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

THE EFFECT OF BRADYKININ AND KALLIDIN ON THE PRESSURE IN THE PULMONARY ARTERY

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

GENERAL AND REGIONAL CIRCULATORY EFFECTS OF SYNTHETIC BRADYKININ IN MAN

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

GENERAL AND REGIONAL CIRCULATORY EFFECTS OF SYNTHETIC ELEDOISIN IN MAN

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Bradykinin: Synthetic Bradykinin : its Biological Identity with Natural Pure Trypsin Bradykinin

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Antihistamine and Antibradykinin Effects of Normal Urine Extracts

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Effect of Bradykinin on Isolated Coronary Arteries

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

[THE BEHAVIOR OF KALLIKREIN INACTIVATOR FROM CATTLE PAROTID GLAND TOWARD ENZYMES, II]

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

EXPERIMENTS ON THE ISOLATION OF THE KALLIKREIN INACTIVATOR. V. THE ISOLATION OF A KALLIKREIN INACTIVATOR FROM THE BOVINE LUNG AND ITS IDENTIFICATION WITH THE INHIBITOR FROM THE BOVINE PAROTID GLAND

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Der Nachweis eines Kreislaufhormons in der Pankreasdrüse. (IV. Mitteilung über dieses Kreislaufhormon.)

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

[Attempts at the isolation of the kallikrein inactivator. III. Electrophoretic purification and molecular weight determination in the ultracentrifuge]

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

[EXPERIMENTS ON THE ISOLATION OF KALLIKREIN INACTIVATOR, IV. CRYSTALLIZATION AND AMINO ACID COMPOSITION. COMPARISON WITH THE TRYPSIN INHIBITOR OF KUNITZ AND NORTHROP]

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Metal ion complexing properties of carcinogen metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Hereditary angioneurotic edema. II. Deficiency of inhibitor for serum globulin permeability factor and/or plasma kallikrein

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

[Antagonism between sodium salicylate and bradykinin in the rat]

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

[Adrenal medulla stimulation by bradykinin]

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Formation of plasma kinins by plasmin

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Plasma‐kinin‐forming enzymes in body fluids and tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Active polypeptides derived from plasma proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

1 reference

7 January 2021

The action of angiotensin and bradykinin on the superior cervical ganglion of the cat

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

THE MODERN TREATMENT OF SHOCK BASED ON PHYSIOLOGIC PRINCIPLES

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

ON THE INFLUENCE OF CHAIN LENGTH ON THE BIOLOGICAL ACTION OF ELEDOISIN ANALOGUE COMPOUNDS

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

USE OF HEPARIN IN DISTINGUISHING PLASMA KALLIKREIN FROM PF/DIL

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

EXPERIMENTAL PANCREATITIS: USE OF A NEW ANTIPROTEOLYTIC SUBSTANCE, TRASYLOL

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Susceptibility of the guinea pig to pharmacological factors from its own serum

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Activation of Endogenous Plasma Proteolytic Enzymes with the Consequent Production of Pharmacologically Active Polypeptides

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Hagerman factor and capillary permeability

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Activation of Hagemen Factor by saturated fatty acids

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

The interrelationship of coagulation of plasma and release of peptides

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Interrelations Between Different Mechanisms of Release of Biologically Active Peptides from Blood Plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

STUDIES ON PLASMA KININS. I. THE COMPOSITION OF KININOGEN COMPLEX

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

On the problem of an antidote in internal thrombotherapy with fibrinolytics

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

[On the effect of protein inhibitor preparations (liver and parotid inhibitor) on extravasal fibrinolysis, fibrinogenolysis and blood coagulation constants in human blood]

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Effects of Bradykinin on the Systemic and Coronary Vascular Bed of the Intact Dog

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

ON THE EFFECT OF SYNTHETIC ELEDOISIN ON KIDNEY FUNCTION, WATER AND ELECTROLYTE BALANCE IN MAN

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

LARGE MOLECULAR SUBSTANCES AS MEDIATORS OF THE INFLAMMATORY REACTION

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Vascular reactions to histamine, histamine-liberator and leukotaxine in the skin of guinea-pigs

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

PROTEOLYTIC ENZYMES IN THE PANCREAS IN NORMAL AND PATHOLOGICAL CONDITIONS

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

ON THE ACTIVATION OF PROTEOLYTIC PROENZYMES OF THE PANCREAS

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

PRESSOR EFFECT OF SYNTHETIC ELEDOISIN IN CHICKENS

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

EFFECT OF ELEDOISIN ON THE SYSTEMIC VENOUS RETURN ON DOGS

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

THE PROTECTIVE EFFECT OF PROTEINASE INHIBITOR IN ACUTE NECROTIZING PANCREATITIS: AN EXPERIMENTAL STUDY

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Synthesis and Biological Properties of L-Arginyl-L-Prolyl-L-Prolyl-Glycyl-L-Phenylalanyl-L-Seryl-L-Phenylalanyl-L-Arginine, an Octapeptide related to Bradykinin

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

The synthesis of a biologically active decapeptide having the structure proposed for kallidin II

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

THE SYNTHESIS OF 8-D-PHENYLALANINE-, 8-P-FLUORO-L-PHENYLALANINE-, AND 8-P-FLUORO-D-PHENYLALANINE-BRADYKININ

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

The synthesis of kinin analogues

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

The permeability to plasma proteins of the peritoneal blood vessels of the mouse, and the effect of substances that alter permeability

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

RELEASE OF A KININ PEPTIDE IN THE CARCINOID SYNDROME

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Hemodynamic effects of eledoisin, kallidin II, and bradykinin in unanesthetized dogs

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

CITRULLINE-CONTAINING ANALOGS OF BRADYKININ

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

STUDIES ON THE PHYSIOLOGICAL ACTIVITY OF THE PEPTIDE RELEASED DURING THE FIBRINOGEN-FIBRIN CONVERSION

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Studies in headache; summary of evidence concerning a noxious agent active locally during migraine headache

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Hemodynamic effects of angiotensin, norepinephrine, and bradykinin continuously measured in unanesthetized dogs

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

VASOPRESSOR RESPONSES TO KALLIDIN, BRADYKININ AND ELEDOISIN IN HYPOTENSIVE RATS

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Homologous serum proteins and their role in phenomena of increased capillary permeability in inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Potentiation of bradykinin action on smooth-muscle by cysteine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Pharmacologically-active polypeptide formed from blood globulin by a cysteine-activated protease from Clostridium histolyticum

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Kallikrein and Histamine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Effect of large doses of aureomycin on human liver

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

CHEMICAL MEDIATORS OF THE ACUTE INFLAMMATORY REACTION

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

ON SOME ANTAGONISTS OF BRADYKININ

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Bradykinin, a hypotensive and smooth muscle stimulating factor released from plasma globulin by snake venoms and by trypsin

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

CARDIAC ACTION OF VASOACTIVE POLYPEPTIDES IN THE RAT. I. BRADYKININ. II. ANGIOTENSIN.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

The systemic and coronary hemodynamic effects of synthetic bradykinin

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Effects on smooth muscle and blood vessels of polypeptides related to bradykinin and to kallidin

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

ROLE OF BRADYKININ IN THE DEVELOPMENT OF ACUTE PANCREATITIS

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Bradykinin and cardiovascular system: estimation of half-life

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Synthesis of eledoisin

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

STUDIES ON SNAKE VENOMS. XV. SEPARATION OF ARGININE ESTER HYDROLASE OF AGKISTRODON HALYS BLOMBOFFII VENOM INTO THREE ENZYMATIC ENTITIES: "BRADYKININ RELEASING", "CLOTTING" AND "PERMEABILITY INCREASING"

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Kinins of different origins

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

[On the behavior of pancreatic enzymes in experimental pancreatitis in the rat]

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

On peptide synthesis. Synthesis of methionyl-lysyl-bradykinin, a kinin from ox blood

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Synthesis and biological action of bradykinin-like undeca-, dodeca- and tridecapeptides

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Bradykinin, kallidin, and their synthetic analogues

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

On peptide synthesis. C-terminal partial sequences of eledoisins and eledoisin analogs

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

D-AMINO ACID-CONTAINING ELEDOISIN ANALOGUES

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

ACUTE EXPERIMENTAL PANCREATITIS: ROLE OF A PROTEOLYTIC ENZYME INHIBITOR IN TREATMENT

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Kininases in Leucocytes and other Tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Bradykinin release and inactivation in man

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

SEROTONIN--BRADYKININ POTENTIATION ON THE PAIN RECEPTORS IN MAN

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Studies on the pectinolytic anaerobes Clostridium flavum and Clostridium laniganii

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Salicylate and Increased Vascular Permeability

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

The activation by irritants of slow-contracting substances, and their relation to the vascular changes of inflammation in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

THE ANTAGONISM OF SUBSTANCES THAT INCREASE VASCULAR PERMEABILITY IN THE RAT

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

EFFECT OF DRUG-RESISTANCE FACTOR R ON THE F PROPERTIES OF ESCHERICHIA COLI

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Synthetic peptides related to eledoisin

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

PURIFICATION OF BOVINE BRADYKININOGEN

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

The release of vasoactive substances in acute pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

[Recent results in the field of plasma kinins]

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

[Spectrophotometric determination of kallikrein and its inactivators]

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

The origin of bradykinin.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

KININ FORMATION BY PLASMIN, AN INDIRECT PROCESS MEDIATED BY ACTIVATION OF KALLIKREIN

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

The effect of bradykinin in an isolated perfused dog lung preparation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Significance of the callicreincallidinogen-callidin system in shock

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

INFLUENCE OF KALLIDIN-L0 ON RENAL FUNCTION

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

The estimation of the kallidins in blood and urine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Action of the kallikreins on synthetic ester substrates

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

The nature of the kallidins released from human plasma by kallikreins and other enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Role of Hageman Factor in the Activation of Vasodilator Activity in Human Plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Immunological properties of the kallikreins

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Significance of histamine in trypsin shock as determined by benadryl.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

[ON THE INHIBITOR OF KALLIKREIN AND TRYPSIN IN THE BOVINE LUNG]

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

[EXPERIMENTS ON THE ISOLATION OF A LOW MOLECULAR KININOGEN]

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

[On the esterase effects of kallikrein and trypsin and their inhibition by kallikrein-and trypsin inhibitors]

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Kallikrein, kallidin, kallikrein inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

[Isolation and structure of kallidine]

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

[THE EFFECTS OF THIOGLYCOLIC ACID ON KININOGEN AND KININASE]

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

RELEASE OF A KININ BY INTRAPERITONEAL INJECTION OF CHEMICAL AGENTS IN MICE

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

ADRENALINE PRECURSORS IN THE INFLAMMATORY REACTION

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

Evidence for the renal origin of urinary kinin

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

MICROCIRCULATORY ASPECTS OF TISSUE INJURY

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960098-8

7 January 2021

29

14

1388

Armstrong

1965

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60098-8

Bollettino della Societa italiana di biologia sperimentale

3 May 2023

38

39

324

Battaglia

1963

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60098-8

Bollettino della Societa italiana di biologia sperimentale

3 May 2023

103

40

72

Ciampolini

1964

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60098-8

3 May 2023

150

14

1390

Eisen

1965

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60098-8

3 May 2023

158

76

16

Elliott

1960

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60098-8

3 May 2023

160

87

21

Elliott

1963

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60098-8

3 May 2023

168

14

1391

Erdös

1965

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60098-8

3 May 2023

202

1

241

Forell

1963

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60098-8

3 May 2023

205

104

247

Fox

1963

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60098-8

3 May 2023

214

104

90

Frey

1963

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60098-8

3 May 2023

282

104

311

Heath

1963

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60098-8

3 May 2023

Physiological Reviews

293

42

265

Hilton

1962

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60098-8

3 May 2023

294

104

273

Hilton

1963

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60098-8

3 May 2023

382

679

195

Lübke

1964

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60098-8

3 May 2023

384

681

25

Lübke

1965

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60098-8

Bollettino della Societa italiana di biologia sperimentale

3 May 2023

399

37

1481

Mariani

1961

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60098-8

3 May 2023

425

14

1396

Moriya

1965

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60098-8

Journal of Medicinal Chemistry

3 May 2023

438

6

1260

Nicolaides

1963

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60098-8

Bollettino della Societa italiana di biologia sperimentale

3 May 2023

455

38

672

Periti

1962

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60098-8

3 May 2023

514

679

207

Schröder

1964

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60098-8

3 May 2023

515

673

220

Schröder

1964

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60098-8

3 May 2023

519

679

221

Schröder

1964

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60098-8

Bollettino della Societa italiana di biologia sperimentale

3 May 2023

526

38

377

Sicuteri

1962

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60098-8

Bollettino della Societa italiana di biologia sperimentale

3 May 2023

528

39

310

Sicuteri

1963

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60098-8

Bollettino della Societa italiana di biologia sperimentale

3 May 2023

530

39

314

Sicuteri

1963

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60098-8

3 May 2023

Pharmacological Reviews

538

10

475

Spector

1958

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60098-8

3 May 2023

539

116

747

Spector

1964

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60098-8

The demonstration of the role of mediators in turpentine pleurisy in rats by experimental suppression of the inflammatory changes

3 May 2023

series ordinal

540

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60098-8

THE EFFECT OF VASCULAR PERMEABILITY FACTORS ON THE EMIGRATION OF LEUCOCYTES

3 May 2023

series ordinal

544

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60098-8

3 May 2023

555

14

1399

Suzuki

1965

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60098-8

3 May 2023

598

60

53

Werle

1948

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60098-8

3 May 2023

Pharmacological Reviews

634

14

251

Wilhelm

1962

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60098-8

3 May 2023

Identifiers

0 references

1 reference